Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

Overview of attention for article published in Targeted Oncology, December 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 99 Dimensions

Readers on

mendeley: 81 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,125 followers.

RT @TargetOncology: Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Ad…

16 Dec 2018

Reply Repost Favourite

RT @TargetOncology: Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Ad…

14 Dec 2018

Reply Repost Favourite

RT @TargetOncology: Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Ad…

14 Dec 2018

Reply Repost Favourite

Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib #openaccess https://t.co/YU6Next9fJ https://t.co/GbcPYWumTs

13 Dec 2018

Reply Repost Favourite